Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT02238626 · COMPLETED
Trial details
- NCT number
- NCT02238626
- Sponsor
- MediciNova
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2017-08-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.